Abstract
A Submission to the Senate Select Committee on COVID-19 on the TRIPS Waiver: Intellectual Property, Access to Essential Medicines, and the Coronavirus COVID-19
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have